A recent study published in JAMA Internal Medicine indicates that mail-order dispensing of mifepristone for medication abortion is effective, feasible, and well-received by patients. Conducted across 11 clinics in seven states, the study assessed 510 abortions among 506 participants who received mifepristone and misoprostol through the mail after an in-person eligibility screening. The results showed that 97.8% of these abortions…
